Scholarly Index
Hakan Demirci
Bursa Yuksek Ihtisas Egitim Ve Arastirma Hastanesi; 9,355 total citations; 319 total publications; best world rank #33
Bursa Yuksek Ihtisas Egitim Ve Arastirma Hastanesi
9,355Total citations
319Total publications
48H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Ocular Oncology and Treatments | Lifetime | 53 | TR 1 | 98.43 |
| Nonmelanoma Skin Cancer Studies | Lifetime | 232 | TR 1 | 97.53 |
| Cutaneous Melanoma Detection and Management | Lifetime | 420 | TR 1 | 97.13 |
| Vascular Tumors and Angiosarcomas | Lifetime | 337 | TR 1 | 95.86 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 288 | TR 3 | 91.83 |
| CNS Lymphoma Diagnosis and Treatment | Lifetime | 595 | TR 1 | 93.53 |
| Facial Rejuvenation and Surgery Techniques | Lifetime | 444 | TR 1 | 93.25 |
| Ocular Infections and Treatments | Lifetime | 723 | TR 2 | 92.99 |
| Retinal and Macular Surgery | Lifetime | 936 | TR 11 | 92.88 |
| Ocular Disorders and Treatments | Lifetime | 654 | TR 5 | 83.42 |
| Drug-Induced Ocular Toxicity | Lifetime | 626 | TR 4 | 72.73 |
| Ocular Oncology and Treatments | 2021-2025 | 33 | TR 1 | 96.78 |
| CNS Lymphoma Diagnosis and Treatment | 2021-2025 | 193 | TR 1 | 89.43 |
| Nonmelanoma Skin Cancer Studies | 2021-2025 | 293 | TR 2 | 88.63 |
| Ocular Diseases and Behçet’s Syndrome | 2021-2025 | 854 | TR 46 | 77.37 |
| IgG4-Related and Inflammatory Diseases | 2021-2025 | 361 | TR 5 | 63.14 |
| Ocular Disorders and Treatments | 2021-2025 | 535 | TR 9 | 33.02 |